Literature DB >> 6704020

Surgical removal of vitreous. Its effect on intraocular fibroblast proliferation in the rabbit.

H T Hsu, K Dorey, N Sorgente, S J Ryan.   

Abstract

The effect of surgical removal of vitreous on intraocular fibroblast proliferation was studied in an animal model. Forty-eight young adult pigmented rabbits were vitrectomized; four groups of eight animals subsequently received intravitreal injection of tissue-cultured rabbit dermal fibroblasts in doses of 50,000, 100,000, 250,000, and 750,000 cells. As controls, eight vitrectomized rabbits received intravitreal culture medium alone, and the remaining eight vitrectomized rabbits were left uninjected. An additional 40 normal rabbits received the same injections of the same four doses and served as nonvitrectomized controls. All animals were observed for 28 days after injection. The results were dose related and showed that vitrectomy aggravated intraocular fibroblast proliferation in that traction retinal detachment occurred earlier and was more severe in the vitrectomized than in the nonvitrectomized controls.

Entities:  

Mesh:

Year:  1984        PMID: 6704020     DOI: 10.1001/archopht.1984.01040030477030

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.

Authors:  S Kuriyama; T Ohuchi; N Yoshimura; Y Honda; M Hiraoka; M Abe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Effect of the vitreous on retinal wound-healing.

Authors:  B Miller; H Miller; R Patterson; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

3.  Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye.

Authors:  T Hida; D B Chandler; S M Sheta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

4.  Pharmacological therapy for proliferative vitreoretinopathy.

Authors:  N D Radtke; A D Weinsieder; R J Ballou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

Review 5.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

6.  Taxol treatment of experimental proliferative vitreoretinopathy.

Authors:  S A Daniels; K G Coonley; M O Yoshizumi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.